This is a Switzerland news story, published by Gizmodo, that relates primarily to the University of Basel news.
For more Switzerland news, you can click here:
more Switzerland newsFor more mental health treatments news, you can click here:
more mental health treatments newsFor more news from Gizmodo, you can click here:
more news from GizmodoOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like mental health treatments news, you might also like this article about
Recreational psychedelic drugs. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest mild acute psychedelic effects news, LSD microdosing news, mental health treatments news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
psychedelic therapyGizmodo
•Health
Health
82% Informative
Researchers at the University of Basel in Switzerland conducted the study.
In people with ADHD, twice weekly low doses of LSD performed no better than placebo at improving their symptoms.
The researchers are careful to note that LSD can still have benefits for other conditions such as depression, however.
VR Score
86
Informative language
91
Neutral language
66
Article tone
semi-formal
Language
English
Language complexity
63
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
long-living
External references
6
Source diversity
5
Affiliate links
no affiliate links
